World Health Organization 11 November 2018 Progress Towards Global Immunization Goals - 2017 Summary presentation of key indicators Updated July 2018

World Health Organization Global and Regional Immunization overage with three doses of diphtheria, tetanus, and pertussis (DTP3) containing vaccines, 1980-2017, global coverage at 85% in 2017 11 November 2018 Source: WHO/UNICEF coverage estimates 2017 revision, July 2018. Immunization Vaccines and Biologicals, (IVB), World Health Organization. 194 WHO Member States. Date of slide: 15 July 2018.

Immunization coverage with DTP3 containing vaccines in infants (from <50%), 2017 <50% (8 countries or 4%) 50-79% (21 countries or 11%) 80-89% (42 countries or 22%) >=90% (123 countries or 63%) Not available Source: WHO/UNICEF coverage estimates 2017 revision, July 2018. Map production: Immunization Vaccines and Biologicals, (IVB). World Health Organization. 194 WHO Member States. Date of slide: 15 July 2018. Not applicable The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. © WHO 2018. All rights reserved.

Countries sustaining >90% DTP3 coverage, 2015-2017 <90% (81 countries or 42%) >=90% (113 countries or 58%) Not available Not applicable The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. © WHO 2018. All rights reserved Source: WHO/UNICEF coverage estimates 2017 revision, July 2018. Map production: Immunization Vaccines and Biologicals, (IVB). World Health Organization. 194 WHO Member States. Date of slide: 15 July 2018.

World Health Organization Coverage with DTP3 containing vaccines, by country income levels, 1980-2017 World Health Organization 11 November 2018 95% High-income countries 85% 78% Global Low-income countries Source: WHO/UNICEF coverage estimates 2017 revision, July 2018, and Country Income Categories (World Bank), as of June 2018. Income classification not available for: Cook Islands and Niue Immunization Vaccines and Biologicals, (IVB), World Health Organization. 194 WHO Member States. Date of slide: 16 July 2018.

Number of countries reached and sustained 90% coverage with 3 doses of DTP containing vaccines since 2000, and global DTP3 coverage Source: WHO/UNICEF coverage estimates 2017 revision,. July 2018. United Nations, Population Division. The World Population Prospects - the 2017 revision". New York, 2017 Immunization Vaccines and Biologicals, (IVB), World Health Organization. 194 WHO Member States. Date of slide: 15 July 2018.

World Health Organization 19.9 million infants not immunized (DTP3), 2017 11 November 2018 Source: WHO/UNICEF coverage estimates 2017 revision, July 2018. United Nations, Population Division. The World Population Prospects - 2017 revision. New York, 2017. Immunization Vaccines and Biologicals, (IVB), World Health Organization. 194 WHO Member States. Date of slide: 15 July 2018.

Top 10 countries with most under- and un-vaccinated children (DTP3), in 2017 Source: WHO/UNICEF coverage estimates 2017 revision, July 2018. Immunization Vaccines and Biologicals, (IVB), World Health Organization. 194 WHO Member States. Date of slide: 18 July 2018.

GLOBAL Annual surviving infants cohort = 136.1 million World Health Organization GLOBAL Annual surviving infants cohort = 136.1 million 11 November 2018 85% DTP3 coverage 116.2 million children vaccinated Source: WHO/UNICEF coverage estimates 2017 revision, July 2018. United Nations, Population Division. The World Population Prospects - 2017 revision. New York, 2017. Immunization Vaccines and Biologicals, (IVB), World Health Organization. 194 WHO Member States. Date of slide: 15 July 2018.

“Developing”* countries with all districts achieving at least 80% DTP3 coverage, 2017 All districts >= 80% (39 countries or 25%) *155 developing countries and economies in transition per UN World Economic & Social Survey, 2018 classification Not all districts >=80% (104 countries or 67%) No district data available (12 countries or 8%) Developed economies (39 countries) Not available Source1: WHO/IVB Database, as at 27 June 2018. Map production: Immunization Vaccines and Biologicals, (IVB). World Health Organization. 194 WHO Member States. Date of slide: 25 July 2018. Not applicable 1. District data not reported in the annual data collection Joint Reporting Form district table of sheet 6 was supplemented from the annual subnational coverage data collection mechanism. The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. © WHO 2018. All rights reserved.

“Developing”* countries with % of districts achieving at least 80% DTP3 coverage, 2017 <50% of districts (30 countries or 19%) *155 developing countries and economies in transition per UN World Economic & Social Survey, 2018 classification 50-79% of districts (31 countries or 20%) 80-99% of districts (43 countries or 28%) 100% of districts (39 countries or 25%) Developed economies (39 countries) Source1: WHO/IVB Database, as at 27 June 2018. Map production: Immunization Vaccines and Biologicals, (IVB). World Health Organization. 194 WHO Member States. Date of slide: 25 July 2018. Not Available (12 countries or 8%) Not applicable 1. District data not reported in the annual data collection Joint Reporting Form district table of sheet 6 was supplemented from the annual subnational coverage data collection mechanism. The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. © WHO 2018. All rights reserved.

World Health Organization 11 November, 2018 Member States by the percent of districts with DTP3 coverage of ≥ 80% for 2017 Not available (34 Member States or 18% with 6 MS having administrative coverage DTP3 data not valid) Not applicable WHO-UNICEF (WUENIC) estimate is < 90% or differs from country administrative coverage reported on the JFR and therefore district data are not considered valid (46 Member States or 24%) 50-79% (32 Member States or 16%, 13 of which administrative coverage DTP3 data considered not valid) < 50% (31 Member States or 16%, 16 of which administrative coverage DTP3 data considered not valid) 80-99% (47 Member States or 24%, 11 of which administrative coverage DTP3 data considered not valid) All districts (50 Member States or 26%, 0 of which administrative coverage DTP3 data considered not valid) Source1: WHO/IVB Database, as at 27 June 2018 and WHO/UNICEF coverage estimates 2017 revision, July 2018. Map production: Immunization Vaccines and Biologicals, (IVB). World Health Organization. 194 WHO Member States. Date of slide: 25 July 2018. 1. District data not reported in the annual data collection Joint Reporting Form district table of sheet 6 was supplemented from the annual subnational coverage data collection mechanism. The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. © WHO 2018. All rights reserved.

Immunization coverage with 1st dose of measles containing vaccines (MCV1) in infants, 2017 <50% (8 countries or 4%) 50-79% (27 countries or 14%) 80-89% (41 countries or 21%) >=90% (118 countries or 61%) Not available Source: WHO/UNICEF coverage estimates 2017 revision, July 2018. Map production: Immunization Vaccines and Biologicals, (IVB). World Health Organization. 194 WHO Member States. Date of slide: 15 July 2018. Not applicable The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. © WHO 2018. All rights reserved.

World Health Organization ARE WE ON TRACK TO REACH OUR GVAP COVERAGE GOALS? Global Immunization 1980-2017 and projections to reach 90% global coverage goals in 2020 - MCV1 coverage 11 November 2018 Source: WHO/UNICEF coverage estimates 2017 revision, July 2018 Immunization Vaccines and Biologicals, (IVB), World Health Organization. 194 WHO Member States. Date of slide: 15 July 2018.

World Health Organization Immunization coverage with Rubella containing vaccines 1st dose* (RCV1) in infants, 2017 11 November, 2018 Coverage estimates are based on WHO and UNICEF estimates of coverage for the dose of measles containing vaccine that corresponds to the first measles-rubella combination vaccine <50% (2 countries or 1%) *coverage estimates for the 1st dose of rubella containing vaccine are based on WHO and UNICEF estimates of coverage of measles containing vaccine. 50-79% (13 countries or 7%) 80-89% (34 countries or 18%) 90-94% (36 countries or 19%) >95% (77 countries or 40%) Source: WHO/UNICEF coverage estimates 2017 revision, July 2018. Map production: Immunization Vaccines and Biologicals, (IVB). World Health Organization. 194 WHO Member States. Date of slide: 17 July 2018. Not available or Rubella vaccine not introduced (32 countries or 16%) Not applicable The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. © WHO 2018. All rights reserved.

World Health Organization Number of countries having introduced Hepatitis B vaccine and global infant coverage for Hepatitis B 3rd dose (HepB3), 1989-2017 11 November 2018 Source: WHO/UNICEF coverage estimates 2017 revision, July 2018, and WHO database as at 06 July 2018. Immunization Vaccines and Biologicals, (IVB), World Health Organization. 194 WHO Member States. Date of slide: 15 July 2018. 2017: excluding 3 countries where HepB administered for adolescents

Immunization coverage with HepB3 in infants, 2017 <50% (7 countries or 4%) 50-79% (24 countries or 13%) 80-89% (40 countries or 22%) >=90% (114 countries or 62%) Source: WHO/UNICEF coverage estimates 2017 revision, July 2018. Map production: Immunization Vaccines and Biologicals, (IVB). World Health Organization. 194 WHO Member States. Date of slide: 15 July 2018. Not available / HepB not introduced or no coverage data available (9 countries or 5%) Not applicable The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. © WHO 2018. All rights reserved.

Pneumococcal and Rotavirus vaccine coverage by income status, 2006-2017 Pneumococcal vaccine introduced in 139* member states Rotavirus vaccine introduced in 96** member states Source: WHO/UNICEF coverage estimates 2017 revision, July 2018. Immunization Vaccines and Biologicals, (IVB), World Health Organization. 194 WHO Member States. Date of slide: 15 July 2018. *partial introduction for 5 countries **partial introduction for 6 countries

Immunization coverage with Pneumococcal Conjugate Vaccine 3rd dose (PCV3) in infants, 2017 <50% (6 countries or 3%) 50-79% (25 countries or 13%) 80-89% (36 countries or 19%) >=90% (67 countries or 35%) PCV in schedule but no coverage data available (5 countries1 or 3%) Source: WHO/UNICEF coverage estimates 2017 revision, July 2018. Map production: Immunization Vaccines and Biologicals, (IVB). World Health Organization. 194 WHO Member States. Date of slide: 15 July 2018. Not available / not in national immunization schedule1 (55 countries1 or 28%) Not applicable 1. Poland reported PCV3 introduction in the 2017 national immunization schedule but data was received on 06 July 2018 and therefore did not meet the WHO/UNICEF coverage estimate deadline. The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. © WHO 2018. All rights reserved.

Immunization coverage with Rotavirus vaccine in infants, 2017 <50% (9 countries or 5%) 50-79% (21 countries or 11%) 80-89% (23 countries or 12%) >=90% (37 countries or 19%) Rotavirus vaccine in schedule but no coverage data available (6 countries1 or 3%) Source: WHO/UNICEF coverage estimates 2017 revision, July 2018. Map production: Immunization Vaccines and Biologicals, (IVB). World Health Organization. 194 WHO Member States. Date of slide: 15 July 2018. Not available / not in national immunization schedule (98 countries1 or 51%) Not applicable 1. Thailand reported partial introduction for a pilot project in two provinces. WHO does not accept pilot projects as included in the national immunization schedule and therefore no coverage estimates were completed. The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. © WHO 2018. All rights reserved.

World Health Organization 11 November 2018 Global coverage estimates, 1980-2017 BCG, DTP1, DTP3, Polio3, MCV1, HepB3 and Hib3 Source: WHO/UNICEF coverage estimates 2017 revision, July 2018. Immunization Vaccines and Biologicals, (IVB), World Health Organization. 194 WHO Member States. Date of Slide: 15 July 2018.

World Health Organization Global coverage estimates, 1980-2017 BCG, DTP 1st and 3rd, Measles 1st and 2nd, Rubella 1st, HepB birth and 3rd, Hib3, Pol3, YFV, PCV3 and Rota (last dose) 11 November 2018 Source: WHO/UNICEF coverage estimates 2017 revision, July 2018. Immunization Vaccines and Biologicals, (IVB), World Health Organization. 194 WHO Member States. Date of Slide: 15 July 2018.

World Health Organization Number of vaccines/antigens introduced in national immunization schedules - 2000 compared to 2017 World Health Organization 11 November 2018 Selected antigens are : Diphtheria, Tetanus, Pertussis, Measles, Polio - universal use Hepatitis B, Heamophilius Influenza type B, Pneumococcal conjugate Rotavirus Rubella 2000 5 antigens (DTP, Measles and Polio) 6 antigens 7 antigens 8 antigens 9 antigens ≥10 antigens Not applicable Source: WHO/IVB Database, as at 27 June 2018. Map production: Immunization Vaccines and Biologicals, (IVB). World Health Organization. 194 WHO Member States. Date of slide: 23 July 2018. 2017 Not available The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. © WHO 2018. All rights reserved.

World Health Organization Countries having introduced Hib vaccine in 1997 and 2017 11 November 2018 1997 29 countries introduced 2 countries partially introduced 2017 190 countries introduced 1 countries partially introduced Source: WHO/UNICEF coverage estimates 2017 revision, July 2018. Map production: Immunization Vaccines and Biologicals, (IVB). World Health Organization. 194 WHO Member States. Date of slide: 15 July 2018. The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. © WHO 2018. All rights reserved.

Polio Eradication Progress, 1988 – 2017 World Health Organization Polio Eradication Progress, 1988 – 2017 11 November 2018 Certified polio-free regions (126 countries) Endemic with wild poliovirus (3 countries) Not certified but non-endemic (65 countries) Source: WHO/POLIO database, as of July 2018. 194 WHO Member States. The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. © WHO 2018. All rights reserved.

World Health Organization Progress in Polio Eradication, Estimated and Reported Polio Cases, 1985-2017 11 November 2018 1988: WHA Resolution to Eradicate Polio 2000: Original Target Date for Interruption of Transmission Reported cases: 2 971 Estimated cases: 3 500 1999: WHA Resolution to accelerate polio eradication activities 2017: Reported wild poliovirus cases: 22 Source: WHO/POLIO database, as of July 2018. 194 WHO Member States.

44 Countries eliminated MNT between 2000 & December 2017 44 Countries eliminated MNT between 2000 & December 2017 *(Plus Ethiopia except Somali region and the South Eastern zone of Nigeria) leaving 15 countries yet to eliminate MNT

Countries providing vitamin A supplementation with routine and/or supplementary immunization activities, 2017 Vitamin A distributed with routine and supplementary immunization activities (14 countries or 7%) Vitamin A distributed only with routine immunization services (55 countries or 28%) Vitamin A distributed only with supplementary immunization activities (6 countries or 3%) Source: WHO/UNICEF database as at 06 July 2018. Map production: Immunization Vaccines and Biologicals, (IVB), World Health Organization. 194 WHO Member States. Date of slide: 11 July 2018. Not available/No Vitamin A distribution (119 countries or %) Not a Countdown country (119) or Countdown country for which Vitamin A deficiency is not a public health problem (2) The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. © WHO 2018. All rights reserved.

World Health Organization Countries with a 3-5 year strategic plan for the national immunization system, 2017 11 November 2018 Yes (149 countries or 77%) No (36 countries or 19%) No data (9 countries or 5%) Not available Source: WHO/IVB Database, as at 06 July 2018. Map production: Immunization Vaccines and Biologicals, (IVB). World Health Organization. 194 WHO Member States. Date of slide: 15 July 2018. Not applicable The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. © WHO 2018. All rights reserved.

World Health Organization Countries with a national annual work plan for immunization services, 2017 11 November 2018 Yes (171 countries or 88%) No (12 countries or 6%) No data (11 countries or 6%) Not available Source: WHO/IVB Database, as at 06 July 2018. Map production: Immunization Vaccines and Biologicals, (IVB). World Health Organization. 194 WHO Member States. Date of slide: 15 July 2018. Not applicable The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. © WHO 2018. All rights reserved.

World Health Organization Countries having a policy being implemented for immunization injection safety, 2017 11 November 2018 Yes (152 countries or 78%) No (20 countries or 10%) No data (22 countries or 11%) Not available Source: WHO/IVB Database, as at 06 July 2018. Map production: Immunization Vaccines and Biologicals, (IVB). World Health Organization. 194 WHO Member States. Date of slide: 15 July 2018. Not applicable The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. © WHO 2017. All rights reserved.

National Immunization Technical Advisory Groups (NITAGs) in 2017 99 Countries meeting the 6 NITAG criteria 131 Countries having a NITAG with administrative or legislative basis 131 Countries Reporting the Existence of A NITAG with Terms of Reference 133 Countries Reporting the Existence of a NITAG Source: WHO/IVB Database, as at 28 June 2018. Map production: Immunization Vaccines and Biologicals, (IVB). World Health Organization. 194 WHO Member States. Date of slide: 15 July 2018. Not available Not applicable The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. © WHO 2018. All rights reserved.